Pulmonary fibrosis: key features and challenges

Elisabetta Renzoni (London, United Kingdom)

Source: International Congress 2015 – PG8 Airway and lung fibrosis
Session: PG8 Airway and lung fibrosis
Session type: Postgraduate Course
Number: 96

PDF journal article, handout or slidesWebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elisabetta Renzoni (London, United Kingdom). Pulmonary fibrosis: key features and challenges. International Congress 2015 – PG8 Airway and lung fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Idiopathic pulmonary fibrosis: current challenges and future perspectives
Source: Eur Respir Rev 2013; 22: 103-105
Year: 2013


Idiopathic pulmonary fibrosis: present understanding and future options
Source: Eur Respir Rev 2011; 20: 132-133
Year: 2011


Idiopathic pulmonary fibrosis: approaches to diagnostic
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002

Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005

Combined pulmonary fibrosis and emphysema: A distinct entity?
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

The myofibroblast in pulmonary fibrosis displays distinct functional characteristics, depending on its source of origin
Source: International Congress 2014 – ILDs 3
Year: 2014

The pathogenesis of pulmonary fibrosis: a moving target
Source: Eur Respir J 2013; 41: 1207-1218
Year: 2013



Distinct clinical and pathological phenotypes in IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Idiopathic pulmonary fibrosis: recent milestones in disease management
Source: Eur Respir Rev 2012; 21: 140
Year: 2012


Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Year: 2020



Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease
Source: Eur Respir J 2016; 48: 26-28
Year: 2016


A recurring theme in pulmonary fibrosis genetics
Source: Eur Respir J, 49 (5) 1700545; 10.1183/13993003.00545-2017
Year: 2017



Pulmonary hypertension: basic concepts and practical management
Source: Eur Respir J 2008; 31: 236-237
Year: 2008


Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Clinical features of combined pulmonary fibrosis and emphysema
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010


Exacerbations in non cystic fibrosis bronchiectasis: clinical features and investigations
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009

Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models
Source: Eur Respir Rev 2014; 23:231-238
Year: 2014



αB-crystallin is involved in the process of pulmonary fibrosis
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010